Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Juni 2017 08:00 ET | Quelle: Spectral Medical Inc.

Spectral's Trial Data to Be Presented at 35th Vicenza Course on AKI and CRRT

TORONTO, ONTARIO--(Marketwired - June 12, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion...
01. Juni 2017 12:57 ET | Quelle: Spectral Medical Inc.

Spectral Announces Voting Results of Annual Meeting

TORONTO, ONTARIO--(Marketwired - June 1, 2017) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT), a Phase III company developing the first treatment for patients with septic...
30. Mai 2017 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Files Final PMA Module for Toraymyxin(TM) With FDA

TORONTO, ONTARIO--(Marketwired - May 30, 2017) - Spectral Medical Inc., ("Spectral" or the "Company"), (TSX:EDT), a Phase III company developing the first treatment for patients with...
12. Mai 2017 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces First Quarter Results

TORONTO, ONTARIO--(Marketwired - May 12, 2017) - Spectral Medical Inc., (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion...
26. April 2017 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Expands Distribution of EAA(TM) In the Middle and Far East and in Europe

TORONTO, ONTARIO--(Marketwired - April 26, 2017) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT), a Phase III company developing the first treatment for patients with...
30. März 2017 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces Fourth Quarter and Fiscal 2016 Results

TORONTO, ONTARIO--(Marketwired - March 30, 2017) - Spectral Medical Inc. (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion...
07. März 2017 08:00 ET | Quelle: Spectral Medical Inc.

U.S. FDA Approves Spectral's Third PMA Module for Its Toraymyxin(TM) Treatment of Endotoxemic Septic Shock

TORONTO, ONTARIO--(Marketwired - March 7, 2017) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT), a Phase III company developing the first treatment for patients with...
23. Februar 2017 08:00 ET | Quelle: Spectral Medical Inc.

Spectral to File Final PMA Module With the FDA for Its Toraymyxin(TM) Treatment of Endotoxemic Septic Shock

TORONTO, ONTARIO--(Marketwired - Feb. 23, 2017) - Spectral Medical Inc., ("Spectral" or the "Company"), (TSX:EDT) a Phase III company developing the first treatment for patients with...
14. Dezember 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Voluntarily Delists From OTCQX

TORONTO, ONTARIO--(Marketwired - Dec. 14, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT)(OTCQX:EDTXF), a Phase III company developing the first treatment for...
05. Dezember 2016 08:00 ET | Quelle: Spectral Medical Inc.

Spectral Announces Appointment of Dr. Masayuki Kaneko to Its Board of Directors

TORONTO, ONTARIO--(Marketwired - Dec. 5, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) (OTCQX:EDTXF) a Phase III company developing the first treatment for...

Vorherige Seite